Clinical Trial Update: A Six-Week Safety Study of an Investigational Ophthalmic Solution [Phase 3]

View source ↗

Summary

A Phase 3 six-week safety study of an investigational ophthalmic solution for allergic conjunctivitis has completed and results were posted. The sponsor is Alco…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• Investigational ophthalmic solution

Snippet

Sponsor: Alcon Research | Conditions: Allergic Conjunctivitis | Phase 3 | Status: COMPLETED | Results posted: 2014-02-28